| GTO ID | GTC1025 |
| Trial ID | ChiCTR2300076953 |
| Disease | Acute Myeloid Leukemia |
| Therapy | CAR-T cell |
| Treatment | BG1805 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Single-arm, Dose-escalation and Dose-expansion Phase I Clinical Study to Evaluate the Tolerability, Safety and Preliminary efficacy of BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia |
| Year | 2023 |
| Country | China |
| Company sponsor | The First Affiliated Hospital, Zhejiang University School of Medicine |
| Cohort 1 | |||||||
|
|||||||